HUM vs TRDA
Humana Inc (HUM) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the HUM and TRDA stock pages for the full models.
Not investment advice.